|01:00 AM ET|
Please join Healthcare partner John Rah as he presents at the Pharmaceutical Compliance Congress and Best Practices Forum.
Closed Session II: Industry Consultant/Legal Counsel Compliance Best Practices Think Tank
Discussion of Priority Issue IV: The IRO and other Monitorships
John Rah | November 5 | 11:45 am–12:30 pm
This session will examine the expectations under a corporate integrity agreement (CIA) as well as the requirements to engage an independent outside expert (referred to as an independent review organization or IRO) that must review and assess various systems, policies, and procedures of companies subject to a CIA.
The panelists will discuss how to prepare for and manage these engagements and approaches to dealing with IROs. By understanding CIA requirements and the dynamics with the IRO, companies are better prepared for this process and more focused on the scope of these reviews. In addition, deferred prosecution agreements and even some CIAs are now requiring engagement of independent monitors that are much more intertwined with ongoing business activities and decisions. Presenters will also provide more information on the role of these monitors and help manage these engagements.
November 3–5, 2014
Hyatt Regency Washington on Capitol Hill
400 New Jersey Avenue, NW
Washington, DC 20001